Menu Search
Equities

Integer Holdings Corp

ITGR:NYQ

Integer Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)140.28
  • Today's Change2.17 / 1.57%
  • Shares traded282.00k
  • 1 Year change+56.70%
  • Beta1.1093
Data delayed at least 15 minutes, as of Nov 25 2024 23:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy3
Outperform6
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The 8 analysts offering 12 month price targets for Integer Holdings Corp have a median target of 142.00, with a high estimate of 147.00 and a low estimate of 130.00. The median estimate represents a 2.82% increase from the last price of 138.11.
High6.4%147.00
Med2.8%142.00
Low-5.9%130.00

Earnings history & estimates in USD

On Oct 24, 2024, Integer Holdings Corp reported 3rd quarter 2024 earnings of 1.43 per share. This result was in line with the consensus of the 7 analysts following the company and exceeded last year's 3rd quarter results by 12.60%.
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate+3.87%
Integer Holdings Corp reported annual 2023 earnings of 4.67 per share on Feb 15, 2024.
Average growth rate+5.48%
More ▼

Revenue history & estimates in USD

Integer Holdings Corporation had 3rd quarter 2024 revenues of 431.42m. This missed the 440.63m consensus estimate of the 8 analysts following the company. This was 13.89% above the prior year's 3rd quarter results.
Average growth rate+1.64%
Integer Holdings Corporation had revenues for the full year 2023 of 1.60bn. This was 16.03% above the prior year's results.
Average growth rate+6.95%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.